Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D) (Breast Cancer Research and Treatment, (2021), 185, 1, (107-116), 10.1007/s10549-020-05915-9)

Noam Pondé, Dominique Agbor‑Tarh, Lissandra Dal Lago, Larissa A. Korde, Florentine Hilbers, Christian Jackisch, Olena Werner, Richard D. Gelber, Aminah Jatoi, Amylou C. Dueck, Alvaro Moreno‑Aspitia, Christos Sotiriou, Evandro de Azambuja, Martine Piccart

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D) (Breast Cancer Research and Treatment, (2021), 185, 1, (107-116), 10.1007/s10549-020-05915-9)'. Together they form a unique fingerprint.

Medicine & Life Sciences